Evaluating the impact of a new antenatal screening for gestational diabetes

Our researchers have lowered the threshold at which women are diagnosed with gestational diabetes. We want to see how this affects pregnancy outcomes.

  • Author's list

    Dharmintra Pasupathy, Catherine Williamson

Diabetes in pregnancy – known as gestational diabetes – affects around 5-8% of pregnant women. The condition affects the body’s ability to control blood sugar levels during pregnancy. 

Women with gestational diabetes typically don’t have any symptoms, and are routinely diagnosed with blood tests between 26 and 28 weeks of pregnancy. 

Unfortunately, gestational diabetes is associated with increased risks for the baby. These include accelerated growth, birth complications and even stillbirth. 

Therefore, it is vital that research into causes and treatment continues. 

In previous research, it became clear that the risk of complications is directly related to the level of glucose in the mother’s blood. This means that women with high blood glucose are more at risk of problems for their baby. 

This study highlighted the benefits of lowering women’s blood glucose levels, even at the lower end of the spectrum. In view of this, the NICE guidelines were updated in 2015 to lower the threshold at which women are diagnosed with gestational diabetes. 

Our research centre has responded by adjusting our own threshold to this lower level. We are currently assessing the impact of this by looking at pregnancy outcomes of affected women. 

In the last 12 months, we have gathered sufficient data and are now analysing the results.

Get our research updates

Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. We can keep you updated on our research news.  If you're interested in being kept updated about our research and news from Tommy's, click here.

This research is funded by Tommy's and takes place in a Tommy's centre.

Read more on this topic

  • Research into premature birth

    Around 60,000 babies are born prematurely each year in the UK. These babies are vulnerable – they are born before they have grown to cope with the outside world. Tommy’s is saving lives by researching how we can prevent premature births by finding those at risk early on.
    Research into premature birth

  • Predicting premature labour using the body’s natural defences

    Our researchers have found that a natural substance made in the vagina and cervix could help us tell whether a woman will go into early labour. The team hope this could lead to new ways to prevent premature birth.
    Predicting premature labour using the body’s natural defences

  • Why does cervical damage cause preterm labour?

    Scientists think that damage to the cervix makes it easier for infections to travel to the womb, resulting in preterm labour. Our researchers have developed a new way to study how this happens, so that we can prevent premature birth and problems it causes.
    Why does cervical damage cause preterm labour?

  • Finding out who’s at risk: how can we predict preterm labour?

    Researchers supported by Tommy’s are building a tool for women with symptoms of threatened preterm labour, to work out how likely they are to give birth too soon.
    Finding out who’s at risk: how can we predict preterm labour?

  • Treating preterm labour with statins

    Tommy’s researchers have shown that statins – drugs normally used to prevent heart disease – could also help to prevent premature birth and the health problems it can cause. Our researchers are now running a clinical trial to test this in pregnant women in preterm labour.
    Treating preterm labour with statins

  • How does inducing labour early affect educational achievement later in life?

    Inducing labour early in uncomplicated pregnancies may reduce the risk of a baby dying, but may also influence their educational achievement later in life. Our researchers are linking information about births to the children’s school records. This will help doctors and parents make informed decisions about inducing labour early.
    How does inducing labour early affect educational achievement later in life?

  • The Preterm Trials Consortium: using long-term trials to answer difficult questions

    Tommy’s is setting up a platform that will help researchers study premature birth more effectively.
    The Preterm Trials Consortium: using long-term trials to answer difficult questions

  • Using statins to prevent brain injury during premature birth

    Premature birth can lead to health problems for the baby, including brain injury. Our researchers are looking into whether statins – drugs to prevent heart disease – could also be used to prevent brain injury in premature babies.
    Using statins to prevent brain injury during premature birth

  • EQUIPTT – testing an app to calculate risk of premature birth

    We are funding a clinical trial to find out whether the QUIPP app – developed by Tommy’s researchers – can help doctors treat women at risk of premature birth. This will help save more babies lives and reduce chances of health problems in the future.
    EQUIPTT – testing an app to calculate risk of premature birth

  • What are the effects of corticosteroids for babies born at term?

    Corticosteroids are given to mothers at risk of premature labour to prevent health complications for their baby. However, many of these women will go on to have a normal birth at term. Our researchers are investigating what effect these drugs have for babies who are not born prematurely after all.
    What are the effects of corticosteroids for babies born at term?

  • Fetal DNA and preterm labour

    Our researchers have been investigating the link between fetal DNA and preterm labour. They have shown that fetal DNA in the blood does not contribute to premature birth or inflammation.
    Fetal DNA and preterm labour

  • What impact does ‘mild’ ICP have on the baby?

    Tommy’s researchers want to find out what the risks are in intrahepatic cholestasis pregnancies with lower levels of bile acids.
    What impact does ‘mild’ ICP have on the baby?